title: Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy.
abstract: Data from an 8-year period for 46 patients with severe acute pancreatitis and infected pancreatic necrosis were analyzed to determine the incidence of fungal infection, to identify risk factors for the development of fungal infection, and to assess the use of early fluconazole treatment. Intraabdominal fungal infection was found in 17 (37%) of 46 patients. Candida albicans was isolated most frequently (15 patients); Candida tropicalis and Candida krusei were found in 1 patient each. Characteristics of patients with fungal infection were not different from patients without fungal infection. The difference in mortality was not statistically significant between patients with fungal infection and patients without fungal infection. Early antifungal therapy (prophylactic or preemptive antifungal therapy) was administered to 18 patients, and only 3 of them developed fungal infection. In this cohort of critically ill patients, no risk factors for fungal infection could be demonstrated, and mortality among patients who received early antifungal therapy was not different. Early treatment with fluconazole seems to prevent fungal infection in these high-risk patients.
authors.affiliation: Intensive Care Unit, Ghent University Hospital, 9000 Gent, Belgium. jan.dewaele@UGent.be
authors.forename: Jan J
authors.initials: JJ
authors.lastname: De Waele
authors.forename: D
authors.initials: D
authors.lastname: Vogelaers
authors.forename: S
authors.initials: S
authors.lastname: Blot
authors.forename: F
authors.initials: F
authors.lastname: Colardyn
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans; D018890:Chemoprevention; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D010195:Pancreatitis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D015725:Fluconazole